Elevation Oncology Stock (NASDAQ: ELEV) stock price, news, charts, stock research, profile.
Open | $2.51 |
Close | $2.70 |
Volume / Avg. | 8.63M / 683.02K |
Day Range | 2.44 - 2.78 |
52 Wk Range | 0.36 - 5.83 |
Market Cap | $145.34M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 34 |
Short Interest | 10.29% |
Days to Cover | 14.35 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Elevation Oncology (NASDAQ:ELEV) through any online brokerage.
Other companies in Elevation Oncology’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Galectin Therapeutics (NASDAQ:GALT), Adverum Biotechnologies (NASDAQ:ADVM), Atossa Therapeutics (NASDAQ:ATOS) and Tevogen Bio Holdings (NASDAQ:TVGN).
There is no analysis for Elevation Oncology.
Elevation Oncology has a consensus price target of $6.14.
The stock price for Elevation Oncology (NASDAQ: ELEV) is $2.66 last updated June 28, 2024 at 4:24 PM EDT.
There are no upcoming dividends for Elevation Oncology.
Elevation Oncology’s Q2 earnings are confirmed for Thursday, August 1, 2024.
There is no upcoming split for Elevation Oncology.
Elevation Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.